Germany· DE-A57-9389c1942e7fce64
Rocuronium Inresa
A medicinal product containing rocuronium bromide, registered in Germany by Inresa Arzneimittel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Rocuronium Bromide
- Manufacturer
- Inresa Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rocuronium bromide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRocuroniumBryant Ranch Prepack
- CzechiaESMERONMerck Sharp & Dohme B.V., Haarlem
- United KingdomEsmeron 100mg/10ml solution for injection vialsOrganon Pharma (UK) Ltd
- BelgiumEsmeron 50 mg/5 mlMSD Belgium
- NetherlandsEsmeron 10 mg/ml, oplossing voor injectieMerck Sharp & Dohme B.V.
- FinlandEsmeronMerck Sharp & Dohme B.V.
- PolandEsmeronMSD Polska Sp. z o.o.
- SwitzerlandEsmeron 100mg/10ml InjektionslösungMSD Merck Sharp & Dohme AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Rocuronium Kalceks, Rocuroniumbromid Accord
- Belgium · Esmeron, Rocuronium B. Braun
- Bulgaria · Рокурониев Ромфарм, Рокурониум Б. Браун
- Cyprus · Esmeron, Rocudem
- Czechia · Esmeron, Rocuronium B. Braun
- Denmark · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
- Estonia · Rocuronium Bromide Fresenius Kabi, Rocuronium Bromide Kalceks
- Spain · Rocuronio Aguettant, Rocuronio B. Braun
- Finland · Rocuronium B. Braun, Rocuronium Bromide Accord
- France · Rocuronium, Rocuronium Aguettant
- United Kingdom (Northern Ireland) · Esmeron, Rocuronium B. Braun Melsungen
- Greece · Esmeron, Rocudem
- Croatia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Fresenius Kabi
- Hungary · Rocuronium Bromide Hameln, Rocuronium Bromide Noridem
- Ireland · Esmeron, Rocuronium
- Iceland · Rocuronium Aguettant
- Italy · Esmeron, Rocuronio Accord
- Lithuania · Rocuronium Bromide Kalceks, Roqurum
- Luxembourg · Esmeron, Rocuronium Bromide Aguettant
- Latvia · Rocuronium Bromide Kalceks
- Malta · Rocuronium Bromide As Kalceks, Rocuronium Bromide Ibigen
- Netherlands · Esmeron, Rocuroniumbromide Accord
- Norway · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
- Poland · Rocuronium, Rocuronium Bromide Hameln
- Portugal · Brometo De Rocurónio Accord, Brometo De Rocurónio Aguettant
- Romania · Esmeron, Rocuronium Aguettant
- Sweden · Rocuronium Accord, Rocuronium B. Braun
- Slovenia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Hameln
- Slovakia · Rocuronium B. Braun, Rocuronium Bromide Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0b131fd-ceb5-4bb3-b831-1bf356743a8a GET /v1/drugs/b0b131fd-ceb5-4bb3-b831-1bf356743a8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Rocuronium Bromide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about rocuronium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.